
    
      General Objectives -To identify the efficacy of the nutritional supplement Ocoxin-viusid to
      increase the quality of life of patients with epithelial advanced or metastatic ovarian
      cancer. Specific Objectives - Identify the influence of the research product on the
      nutritional status and quality of life of patients. - Describe the toxicity of the research
      product. - Identify the adverse reactions to the chemotherapy scheme and quantify the
      interruptions to it by acute toxicity.

      Quality of life. It will be measured as: - EORTC Questionnaire QLQ-C30 (Score of each item
      and general score). Measurement time: at the beginning and 3 weeks after the 3rd cycle of QT
      - EORTC Questionnaire QLQ-OV28 (Score of each item and general score). Measurement time: at
      the beginning and 3 weeks after the 3rd cycle of QT - Karnofsky index (Score of 0-100 points
      at intervals of 10). Measurement time: at the beginning, in each cycle of QT and 3 weeks
      after the 3rd cycle of QT
    
  